Technoderma Medicines Completes Phase 1 Dose Escalation Clinical Trial of TDM-180935 for Atopic Dermatitis

CHENGDU, China, Dec. 4, 2023 /PRNewswire/ — Technoderma Medicines, Inc. ("the Company"),…

Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck

SHANGHAI, Dec. 4, 2023 /PRNewswire/ — On 4 Dec. 2023, Abbisko Therapeutics…

Viction Horizon's Startup Hackathon to offer over $300,000 in prizes

HO CHI MINH CITY, Vietnam, Dec. 4, 2023 /PRNewswire/ — The official…

GLOBAL CENTRE LAUNCHED TO ACCELERATE CLIMATE FINANCE

Pioneering new Global Climate Finance Centre in Abu Dhabi to accelerate global…

The 2023 Understanding China Conference: Gathering and Revealing Diverse Insights on Convergence of Interests for a Shared Future

GUANGZHOU, China, Dec. 4, 2023 /PRNewswire/ — The 2023 Understanding China Conference…

Farmmi Ships Latest Order to Canada; Company Continues to Benefit from Healthy North American Demand

LISHUI, China, Dec. 4, 2023 /PRNewswire/ — Farmmi, Inc. ("Farmmi" or the "Company")…

IBM Debuts Next-Generation Quantum Processor & IBM Quantum System Two, Extends Roadmap to Advance Era of Quantum Utility

University of Tokyo, Argonne National Laboratory, Fundacion Ikerbasque, Qedma, Algorithmiq, University of Washington,…